$JNJ

1 thesis
bullish 0%neutral 0%bearish 100%
Avg return (3m)
Win rate (3m)
(0 resolved)

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

$JNJSEC Form 4bearish
Sold 15,000 @ $263.36 avg · $3,950,400 · 2026-08-17

Form 4: Taubert Jennifer L sold JNJ

Taubert Jennifer L (EVP, WWC. Innovative Medicine at JOHNSON & JOHNSON) reported an open-market sale of 15,000 shares of JNJ at an average $263.36, roughly $3,950,400, in a Form 4 filed 2026-08-18.

View filing on SEC.gov →

End of results.